| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | BHLHE41 NEURL2 PDGFRB ADGRB1 OBSCN NIBAN2 FKTN MTOR EHD1 PLEC MMP14 TNNT3 | 1.12e-05 | 391 | 136 | 12 | GO:0051146 |
| GeneOntologyBiologicalProcess | myotube differentiation | 1.34e-05 | 164 | 136 | 8 | GO:0014902 | |
| GeneOntologyCellularComponent | anchoring junction | NEURL2 DSC2 PDGFRB ANXA1 CAPN1 ADGRB1 OBSCN NIBAN2 AKAP12 LIN7A HMCN1 AHNAK SYNE2 TJP2 KIFC3 PLEC ATP1A1 PATJ MMP14 TJP3 | 8.10e-06 | 976 | 140 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | motile cilium | DNHD1 DNAH3 ANXA1 CFAP36 IFT172 PRAMEF2 LDHA AKAP9 ATP1A1 SLC26A6 | 1.43e-04 | 355 | 140 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | cell-cell junction | DSC2 ANXA1 ADGRB1 OBSCN NIBAN2 LIN7A HMCN1 AHNAK TJP2 KIFC3 ATP1A1 PATJ TJP3 | 1.75e-04 | 591 | 140 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | cell-substrate junction | NEURL2 PDGFRB ANXA1 CAPN1 ADGRB1 AKAP12 HMCN1 AHNAK SYNE2 PLEC MMP14 | 2.00e-04 | 443 | 140 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | cilium | DNHD1 DNAH3 ANXA1 CFAP36 IFT172 PRAMEF2 LDHA IFT43 AKAP9 EHD1 ATP1A1 CPLANE1 KIF17 SLC26A6 TTLL13 INVS | 3.45e-04 | 898 | 140 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.27e-04 | 94 | 140 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | adherens junction | 5.75e-04 | 212 | 140 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | procentriole replication complex | 6.56e-04 | 6 | 140 | 2 | GO:0120099 | |
| GeneOntologyCellularComponent | deuterosome | 6.56e-04 | 6 | 140 | 2 | GO:0098536 | |
| GeneOntologyCellularComponent | muscle tendon junction | 6.56e-04 | 6 | 140 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.13e-03 | 238 | 140 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | cornified envelope | 1.19e-03 | 69 | 140 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.66e-03 | 405 | 140 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | sarcolemma | 1.79e-03 | 190 | 140 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.93e-03 | 10 | 140 | 2 | GO:0036156 | |
| MousePheno | abnormal blood circulation | RNASEH2B ERBB3 TRPV1 ABCA3 PLOD3 PDGFRB GLRX3 IFT172 APAF1 LAMA4 CHD2 SMG5 AKAP12 JARID2 MECR CHRD FNIP1 PLCG2 PLEC TNNT3 MMUT INVS | 9.06e-07 | 845 | 113 | 22 | MP:0002128 |
| MousePheno | hemorrhage | RNASEH2B ABCA3 PLOD3 PDGFRB GLRX3 IFT172 APAF1 LAMA4 CHD2 SMG5 JARID2 MECR CHRD PLCG2 PLEC TNNT3 MMUT INVS | 5.89e-06 | 664 | 113 | 18 | MP:0001914 |
| MousePheno | abnormal basement membrane morphology | 1.66e-05 | 40 | 113 | 5 | MP:0004272 | |
| MousePheno | abnormal renal glomerulus morphology | 5.48e-05 | 264 | 113 | 10 | MP:0005325 | |
| MousePheno | abnormal embryo development | RNASEH2B PLOD3 GLRX3 IFT172 MTERF3 NOC3L CHD1 UPF1 IFT43 CHRND NCOR2 POGLUT1 MECR FBXO5 HMCN1 FKTN MTOR CHRD TJP2 SASS6 KDM8 CPLANE1 SLC33A1 EIF3M INVS | 7.73e-05 | 1370 | 113 | 25 | MP:0001672 |
| MousePheno | impaired basement membrane formation | 8.10e-05 | 11 | 113 | 3 | MP:0003044 | |
| MousePheno | increased heart ventricle size | 8.61e-05 | 175 | 113 | 8 | MP:0008772 | |
| MousePheno | abnormal renal corpuscle morphology | 1.30e-04 | 293 | 113 | 10 | MP:0002827 | |
| Domain | DUF4208 | 1.62e-04 | 3 | 138 | 2 | PF13907 | |
| Domain | DUF4208 | 1.62e-04 | 3 | 138 | 2 | IPR025260 | |
| Domain | ZO | 1.62e-04 | 3 | 138 | 2 | IPR005417 | |
| Domain | DUF4208 | 1.62e-04 | 3 | 138 | 2 | SM01176 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | HNRNPDL ANXA1 CFAP36 CAPN1 SQLE NOC3L PSMD12 NIBAN2 UPF1 RFC2 LDHA AKAP12 NCOR2 PDE12 SPATS2L COMMD8 MTOR AHNAK SYNE2 AHCY TJP2 GSDMA ATP1A1 EIF3M MMUT | 2.27e-10 | 1367 | 140 | 25 | 32687490 |
| Pubmed | ANXA1 CAPN1 NOC3L CHD1 CHD2 PSMD12 UPF1 TEX10 TASOR2 IGF2BP3 MTOR AHNAK SYNE2 GNL2 TJP2 PLEC ATP1A1 | 1.34e-09 | 653 | 140 | 17 | 22586326 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HNRNPDL PALD1 TBRG4 VWA8 CFAP36 MTERF3 RANBP6 RTN3 RTN4IP1 UPF1 FLG2 TTC3 NBAS IGF2BP3 PDE12 SPATS2L AKAP9 OSBPL3 SYNE2 GNL2 SASS6 ATP1A1 HERC1 SLC33A1 MMUT | 1.44e-09 | 1496 | 140 | 25 | 32877691 |
| Pubmed | PALD1 TBRG4 PLOD3 VWA8 GLRX3 NOC3L RANBP6 L2HGDH PSMD12 UPF1 RFC2 LDHA WDR26 NBAS IGF2BP3 COMMD8 MTOR AHNAK SYNE2 EHD1 GNL2 TJP2 ATP1A1 EIF3M | 3.39e-09 | 1440 | 140 | 24 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HNRNPDL ANXA1 CAPN1 NOC3L CHD1 CHD2 UPF1 SRBD1 RFC2 TEX10 LDHA NCOR2 PDE12 MAP4K5 AHNAK EHD1 AHCY GSDMA PLCG2 PLEC MMP14 EIF3M | 2.57e-08 | 1353 | 140 | 22 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPDL PLOD3 ANXA1 CAPN1 NOC3L UPF1 SRBD1 RFC2 FLG2 TEX10 LDHA TASOR2 SPATS2L AHNAK AHCY GNL2 TJP2 GSDMA PLEC PATJ EIF3M | 3.50e-08 | 1257 | 140 | 21 | 36526897 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 5.15e-08 | 84 | 140 | 7 | 25670202 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | ANXA1 PSMD12 UPF1 RFC2 FLG2 LDHA AKAP12 IGF2BP3 MTOR AHNAK EHD1 AHCY GSDMA PLEC EIF3M | 6.05e-08 | 647 | 140 | 15 | 26618866 |
| Pubmed | PALD1 DSC2 GLRX3 STK38 PSMD12 NIBAN2 UPF1 AKAP12 FBXO5 MAP4K5 AHNAK EHD1 AHCY ATP1A1 PATJ | 1.92e-07 | 708 | 140 | 15 | 39231216 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RNASEH2B GLRX3 CAPN1 RANBP6 IREB2 PSMD12 NIBAN2 RFC2 LDHA WDR26 AKAP12 IGF2BP3 PDE12 MTOR AHNAK EHD1 AHCY TJP2 PLEC HERC1 EIF3M | 3.97e-07 | 1455 | 140 | 21 | 22863883 |
| Pubmed | 4.73e-07 | 304 | 140 | 10 | 32235678 | ||
| Pubmed | VWA8 ANXA1 IREB2 CHD2 UPF1 RFC2 FLG2 TEX10 LDHA IGF2BP3 SPATS2L AKAP9 OSBPL3 AHNAK EHD1 AHCY GNL2 TJP2 PLEC ATP1A1 | 6.56e-07 | 1371 | 140 | 20 | 36244648 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VWA8 ANXA1 NOC3L ADGRB1 PSMD12 NIBAN2 SRBD1 RFC2 TEX10 WDR26 LIN7A PDE12 GNL2 TJP2 SASS6 PLEC EIF3M | 6.66e-07 | 1005 | 140 | 17 | 19615732 |
| Pubmed | HNRNPDL PLOD3 ANXA1 CAPN1 FLG2 LDHA IGF2BP3 AHNAK AHCY TJP2 PLEC ATP1A1 | 7.33e-07 | 488 | 140 | 12 | 31324722 | |
| Pubmed | HNRNPDL ANXA1 PSMD12 UPF1 LDHA AKAP12 IGF2BP3 PDE12 AHNAK AHCY PLEC EIF3M | 8.33e-07 | 494 | 140 | 12 | 26831064 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PLOD3 ANXA1 RPS6KA2 STK38 CHD1 CHD2 TEX10 WDR26 NCOR2 AKAP9 MAP4K5 AHCY PLEC CPLANE1 STK38L EIF3M | 8.80e-07 | 910 | 140 | 16 | 36736316 |
| Pubmed | HNRNPDL SQLE PSMD12 UPF1 LDHA IGF2BP3 KMT2D PDE12 SPATS2L EHD1 TJP2 PLEC ATP1A1 EIF3M | 1.19e-06 | 711 | 140 | 14 | 33022573 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HNRNPDL ANXA1 CAPN1 SMG5 NIBAN2 UPF1 TTC3 AKAP12 IGF2BP3 SPATS2L AHNAK TJP2 PLEC ATP1A1 | 1.48e-06 | 724 | 140 | 14 | 36232890 |
| Pubmed | PLOD3 DSC2 VWA8 MTERF3 APAF1 NOC3L RTN3 CHD1 RTN4IP1 NIBAN2 UPF1 TTC3 AKAP12 NBAS PDE12 AKAP9 MAP4K5 SYNE2 GNL2 SLC33A1 | 2.27e-06 | 1487 | 140 | 20 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 PALD1 PLOD3 VWA8 RPS6KA2 OBSCN SMG5 TTC3 NCOR2 KMT2D MTOR AHNAK KIFC3 PLEC HERC1 MMP14 TJP3 | 2.41e-06 | 1105 | 140 | 17 | 35748872 |
| Pubmed | 2.65e-06 | 54 | 140 | 5 | 36237976 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | HNRNPDL STK38 UPF1 FLG2 SPATS2L AHNAK CCDC87 GSDMA PLEC ATP1A1 STK38L EIF3M | 2.93e-06 | 558 | 140 | 12 | 27591049 |
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 19786558 | ||
| Pubmed | 3.76e-06 | 224 | 140 | 8 | 32941674 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HNRNPDL GLRX3 ANXA1 STK38 PSMD12 UPF1 RFC2 LDHA WDR26 AKAP12 IGF2BP3 AHNAK AHCY PLEC ATP1A1 PATJ STK38L | 4.04e-06 | 1149 | 140 | 17 | 35446349 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HNRNPDL TBRG4 PLOD3 VWA8 GLRX3 ANXA1 CHD1 UPF1 RFC2 FLG2 LDHA IGF2BP3 AHNAK SYNE2 AHCY GNL2 PLEC ATP1A1 EIF3M | 4.28e-06 | 1415 | 140 | 19 | 28515276 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HNRNPDL STK38 XDH NIBAN2 NRIP3 AKAP12 TASOR2 NBAS IGF2BP3 KANSL2 FBXO5 AHNAK AHCY SASS6 CEP152 KIFC3 EIF3M | 4.33e-06 | 1155 | 140 | 17 | 20360068 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HNRNPDL DNHD1 TBRG4 PDGFRB NOC3L RTN3 CHD1 PSMD12 UPF1 RFC2 LDHA TTC3 JARID2 PDE12 MTOR AHCY GNL2 ATP1A1 EIF3M | 4.73e-06 | 1425 | 140 | 19 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GLRX3 ANXA1 CAPN1 RTN3 PSMD12 NIBAN2 UPF1 LDHA NBAS AKAP9 AHNAK AHCY PLEC ATP1A1 | 5.15e-06 | 807 | 140 | 14 | 30575818 |
| Pubmed | GLRX3 LAMA4 RANBP6 NIBAN2 TEX10 TTC3 NCOR2 KMT2D PLCG2 PLEC HERC1 INVS | 5.26e-06 | 591 | 140 | 12 | 15231748 | |
| Pubmed | 7.26e-06 | 245 | 140 | 8 | 35652658 | ||
| Pubmed | 7.92e-06 | 417 | 140 | 10 | 19199708 | ||
| Pubmed | 8.45e-06 | 331 | 140 | 9 | 29199018 | ||
| Pubmed | 9.17e-06 | 253 | 140 | 8 | 29911972 | ||
| Pubmed | Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis. | 1.03e-05 | 184 | 140 | 7 | 23402259 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DSC2 RPS6KA2 WDR26 AKAP9 MTOR OSBPL3 AHNAK SYNE2 TJP2 FNIP1 CEP152 PLEC PATJ FGD6 | 1.07e-05 | 861 | 140 | 14 | 36931259 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | RNASEH2B DSC2 CFAP36 SQLE ADGRB1 PRAMEF2 LDHA BHLHE40 JARID2 AKAP9 MECR MTOR OSBPL3 EHD1 KDM8 HERC1 ST18 | 1.12e-05 | 1242 | 140 | 17 | 30973865 |
| Pubmed | HNRNPDL VWA8 STK38 PSMD12 UPF1 NCOR2 IGF2BP3 SYNE2 GRIP2 KDM8 PLCG2 SLC33A1 EIF3M | 1.21e-05 | 754 | 140 | 13 | 35906200 | |
| Pubmed | HNRNPDL STK38 UPF1 SRBD1 LDHA WDR26 TASOR2 IGF2BP3 AHCY PLEC STK38L | 1.54e-05 | 551 | 140 | 11 | 34728620 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23605953 | ||
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 1.61e-05 | 2 | 140 | 2 | 25601544 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12354771 | ||
| Pubmed | Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis. | 1.61e-05 | 2 | 140 | 2 | 34293399 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25340473 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30138330 | ||
| Pubmed | Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. | 1.61e-05 | 2 | 140 | 2 | 18648504 | |
| Pubmed | The Potential Roles of Dec1 and Dec2 in Periodontal Inflammation. | 1.61e-05 | 2 | 140 | 2 | 34638690 | |
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 1.61e-05 | 2 | 140 | 2 | 25297984 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28711648 | ||
| Pubmed | Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. | 1.61e-05 | 2 | 140 | 2 | 21531719 | |
| Pubmed | CED-4 is an mRNA-binding protein that delivers ced-3 mRNA to ribosomes. | 1.61e-05 | 2 | 140 | 2 | 26740177 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 38448474 | ||
| Pubmed | UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma. | 1.61e-05 | 2 | 140 | 2 | 34520393 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35257799 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9771707 | ||
| Pubmed | Altered Stra13 and Dec2 circadian gene expression in hypoxic cells. | 1.61e-05 | 2 | 140 | 2 | 18342625 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22330140 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12624110 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21327324 | ||
| Pubmed | A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing. | 1.61e-05 | 2 | 140 | 2 | 30099721 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15037617 | ||
| Pubmed | HNRNPDL DSC2 CFAP36 NOC3L FLG2 LDHA AKAP12 TASOR2 IGF2BP3 AHNAK EHD1 TJP2 ATP1A1 | 1.66e-05 | 777 | 140 | 13 | 35844135 | |
| Pubmed | 1.95e-05 | 136 | 140 | 6 | 22304920 | ||
| Pubmed | PALD1 DSC2 STK38 NIBAN2 AKAP12 NBAS AHNAK SYNE2 EHD1 AHCY SLC33A1 | 2.04e-05 | 568 | 140 | 11 | 37774976 | |
| Pubmed | HNRNPDL PSMD12 UPF1 SRBD1 LDHA IGF2BP3 SPATS2L AHCY ATP1A1 EIF3M | 2.18e-05 | 469 | 140 | 10 | 37314180 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 2.27e-05 | 375 | 140 | 9 | 32788342 | |
| Pubmed | HNRNPDL DNAH3 PLOD3 ANXA1 NOC3L PSMD12 UPF1 FLG2 LDHA AHNAK AHCY PLEC ATP1A1 | 2.34e-05 | 803 | 140 | 13 | 36517590 | |
| Pubmed | 2.80e-05 | 15 | 140 | 3 | 31672844 | ||
| Pubmed | 2.80e-05 | 15 | 140 | 3 | 23782696 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | HNRNPDL CAPN1 APAF1 PSMD12 UPF1 RFC2 NBAS IGF2BP3 PDE12 MTOR AHCY ATP1A1 | 2.97e-05 | 704 | 140 | 12 | 29955894 |
| Pubmed | HNRNPDL OBSCN RTN4IP1 CHD2 PRAMEF2 TTC3 AKAP12 OSBPL3 TJP2 PLEC HERC1 PATJ CPLANE1 SLC33A1 UBE2Q2 | 3.35e-05 | 1084 | 140 | 15 | 11544199 | |
| Pubmed | MTERF3 APAF1 CHD1 PSMD12 TASOR2 SPATS2L FNIP1 PLEC POLQ EIF3M | 3.49e-05 | 496 | 140 | 10 | 31343991 | |
| Pubmed | 3.53e-05 | 397 | 140 | 9 | 21319273 | ||
| Pubmed | 3.55e-05 | 497 | 140 | 10 | 23414517 | ||
| Pubmed | DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. | 3.60e-05 | 46 | 140 | 4 | 11423996 | |
| Pubmed | 3.96e-05 | 227 | 140 | 7 | 26410627 | ||
| Pubmed | 4.11e-05 | 312 | 140 | 8 | 37120454 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 4.26e-05 | 95 | 140 | 5 | 27129302 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 4.50e-05 | 316 | 140 | 8 | 31665637 | |
| Pubmed | 4.80e-05 | 234 | 140 | 7 | 36243803 | ||
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 4.81e-05 | 3 | 140 | 2 | 21262772 | |
| Pubmed | Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. | 4.81e-05 | 3 | 140 | 2 | 19098224 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 22376253 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 23897809 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 24243494 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 29934494 | ||
| Pubmed | Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. | 4.81e-05 | 3 | 140 | 2 | 29233126 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 23828042 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 26892246 | ||
| Pubmed | Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells. | 4.81e-05 | 3 | 140 | 2 | 26391953 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 18345027 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 19538286 | ||
| Pubmed | TFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41. | 4.81e-05 | 3 | 140 | 2 | 33176151 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 25486565 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 34634811 | ||
| Pubmed | Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self-renewal and identity. | 4.81e-05 | 3 | 140 | 2 | 31414712 | |
| Pubmed | CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage. | 4.81e-05 | 3 | 140 | 2 | 33022763 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 12021270 | ||
| Pubmed | Hypoxia-inducible factor 1 regulation through cross talk between mTOR and MT1-MMP. | 4.81e-05 | 3 | 140 | 2 | 24164895 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 23348841 | ||
| GeneFamily | PDZ domain containing | 1.05e-04 | 152 | 89 | 6 | 1220 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 8.43e-04 | 9 | 89 | 2 | 1223 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN | 1.36e-06 | 200 | 140 | 9 | M8046 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | PLA2G7 RALGDS PDGFRB LAMA4 XDH TTC3 BHLHE40 AKAP12 TXNDC16 MMP14 VDR | 1.02e-05 | 398 | 140 | 11 | M7514 |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.22e-05 | 199 | 140 | 8 | M6264 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.26e-05 | 200 | 140 | 8 | M5831 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN | 1.26e-05 | 200 | 140 | 8 | M5135 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.26e-05 | 200 | 140 | 8 | M3020 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | PLA2G7 RALGDS PDGFRB LAMA4 XDH TTC3 BHLHE40 AKAP12 TXNDC16 MMP14 VDR | 1.71e-05 | 421 | 140 | 11 | MM985 |
| Coexpression | PGF_UP.V1_UP | 7.51e-05 | 190 | 140 | 7 | M2674 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | PDGFRB ANXA1 LAMA4 LDHA BHLHE40 AKAP12 JARID2 SPATS2L HMCN1 AHNAK STK38L EIF3M VDR | 7.68e-05 | 681 | 140 | 13 | M39175 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 8.14e-05 | 260 | 140 | 8 | M41075 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 8.83e-05 | 195 | 140 | 7 | M7382 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 8.83e-05 | 195 | 140 | 7 | M7397 | |
| Coexpression | GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN | 9.12e-05 | 196 | 140 | 7 | M4433 | |
| Coexpression | ERBB2_UP.V1_DN | 9.42e-05 | 197 | 140 | 7 | M2635 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 9.72e-05 | 198 | 140 | 7 | M7200 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 1.00e-04 | 199 | 140 | 7 | M4567 | |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 1.00e-04 | 199 | 140 | 7 | M7496 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 1.00e-04 | 199 | 140 | 7 | M6612 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP | 1.00e-04 | 199 | 140 | 7 | M5709 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP | 1.03e-04 | 200 | 140 | 7 | M9380 | |
| Coexpression | GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP | 1.03e-04 | 200 | 140 | 7 | M7064 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN | 1.03e-04 | 200 | 140 | 7 | M8543 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN | 1.03e-04 | 200 | 140 | 7 | M3610 | |
| Coexpression | GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP | 1.03e-04 | 200 | 140 | 7 | M6476 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN | 1.03e-04 | 200 | 140 | 7 | M4062 | |
| Coexpression | GSE17721_0.5H_VS_4H_CPG_BMDC_DN | 1.03e-04 | 200 | 140 | 7 | M4125 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | PLA2G7 ERBB3 DSC2 ANXA1 RPS6KA2 CAPN1 STK38 NIBAN2 LDHA BHLHE40 SPATS2L AHNAK SYNE2 TJP2 ATP1A1 PATJ STK38L FGD6 | 1.60e-04 | 1276 | 140 | 18 | M39173 |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN | 1.77e-04 | 153 | 140 | 6 | M6338 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERBB3 ANXA1 NIBAN2 S100A2 AKAP9 AHNAK SYNE2 TJP2 ATP1A1 CPLANE1 | 8.35e-10 | 200 | 140 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.50e-08 | 200 | 140 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | (03)_KRT6B+-(1)_GFP|(03)_KRT6B+ / shred by cell type by condition | 2.31e-07 | 199 | 140 | 8 | 10493933a3dc330e40595ec0c001428b9d68f17e | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.31e-07 | 199 | 140 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-07 | 200 | 140 | 8 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-liver_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.89e-07 | 154 | 140 | 7 | acfbde0fbc09fd69af62a81f8f63e14e36dd1ae0 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 187 | 140 | 7 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 187 | 140 | 7 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 187 | 140 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 195 | 140 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 195 | 140 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mLN-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.05e-06 | 197 | 140 | 7 | 5e39a49dddef04469ff2b615d755ddf6a926e58e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.05e-06 | 197 | 140 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-06 | 197 | 140 | 7 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | mLN-T_cell-Th1|mLN / Region, Cell class and subclass | 3.15e-06 | 198 | 140 | 7 | 7627b7c3a248da2bd5e1e6f7c226e5fd0bc92113 | |
| ToppCell | mLN-(1)_T_cell-(12)_Th1|mLN / shred on region, Cell_type, and subtype | 3.15e-06 | 198 | 140 | 7 | 1fe8257233232b264b9ca630c2d92c509a195353 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 198 | 140 | 7 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.15e-06 | 198 | 140 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.26e-06 | 199 | 140 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 3.26e-06 | 199 | 140 | 7 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 3.37e-06 | 200 | 140 | 7 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-06 | 200 | 140 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 156 | 140 | 6 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 1.59e-05 | 169 | 140 | 6 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.70e-05 | 171 | 140 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_THEMIS_ELOF1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-05 | 176 | 140 | 6 | 78306517b1e52411a2ba72f141efea4d12c09f25 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.20e-05 | 179 | 140 | 6 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.34e-05 | 181 | 140 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 183 | 140 | 6 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 184 | 140 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 184 | 140 | 6 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-05 | 185 | 140 | 6 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-05 | 111 | 140 | 5 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-05 | 188 | 140 | 6 | 3e3055dacc05a932f2beb114babf1dc76994e1af | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.90e-05 | 188 | 140 | 6 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.99e-05 | 189 | 140 | 6 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-05 | 189 | 140 | 6 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 189 | 140 | 6 | 4bc3826e0515b3cf2e2ef72a7b2cf9c32ade1812 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.99e-05 | 189 | 140 | 6 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-05 | 192 | 140 | 6 | ee9a23a4f00424a50bd7907cf3b12dc50027877e | |
| ToppCell | 15-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 3.46e-05 | 194 | 140 | 6 | ac0e48b0c09a7f57d30dff321b0c30a4c5e16ad9 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.46e-05 | 194 | 140 | 6 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | 15-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 3.46e-05 | 194 | 140 | 6 | f3851337a2d17f4acef2cd812a766eb0b503748b | |
| ToppCell | tumor_Lung|World / Location, Cell class and cell subclass | 3.46e-05 | 194 | 140 | 6 | 7e6b8a30f8d08252ad3f1df826d6f7c0ba997c2c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.56e-05 | 195 | 140 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-05 | 195 | 140 | 6 | 36d4a11bc77a4cc97a22525c78ef8359f4a3ca66 | |
| ToppCell | (5)_Epi_stratified|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.76e-05 | 197 | 140 | 6 | 2b35bcff0637cd5af9bec1ac6bca2b59a92e2f64 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.76e-05 | 197 | 140 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-05 | 197 | 140 | 6 | 4623cce5eca0c26c8103950e9874b40918226aa5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-05 | 197 | 140 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue | 3.76e-05 | 197 | 140 | 6 | bcb4dc17dae705bd84ea6a2842d6b107562baeb7 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.76e-05 | 197 | 140 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mLN-T_cell-Th17|mLN / Region, Cell class and subclass | 3.87e-05 | 198 | 140 | 6 | 04905f62941b193864704a10ad692faf777fa51d | |
| ToppCell | mLN-(1)_T_cell-(13)_Th17|mLN / shred on region, Cell_type, and subtype | 3.87e-05 | 198 | 140 | 6 | c575e9aeee4e034e8c4d171fe754403652343731 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 3.87e-05 | 198 | 140 | 6 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_stratified|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.87e-05 | 198 | 140 | 6 | b3aec042912ce53bd86e86b6761a0604d9998ab5 | |
| ToppCell | (5)_Epithelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.87e-05 | 198 | 140 | 6 | 6dd7dd356d55c03bb14fa47cc69764403c3f48d4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 198 | 140 | 6 | 96d46e73f968391000ecd14c787efb93c79f96ec | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 3.98e-05 | 199 | 140 | 6 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.98e-05 | 199 | 140 | 6 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 3.98e-05 | 199 | 140 | 6 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.98e-05 | 199 | 140 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-05 | 199 | 140 | 6 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 3.98e-05 | 199 | 140 | 6 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.98e-05 | 199 | 140 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.98e-05 | 199 | 140 | 6 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.98e-05 | 199 | 140 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.10e-05 | 200 | 140 | 6 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.10e-05 | 200 | 140 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.10e-05 | 200 | 140 | 6 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.10e-05 | 200 | 140 | 6 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 132 | 140 | 5 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.34e-05 | 133 | 140 | 5 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.81e-05 | 135 | 140 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-05 | 137 | 140 | 5 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.15e-04 | 151 | 140 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 151 | 140 | 5 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 153 | 140 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 154 | 140 | 5 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 1.27e-04 | 154 | 140 | 5 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 156 | 140 | 5 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.39e-04 | 157 | 140 | 5 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 157 | 140 | 5 | a84377028c661f8f3ecae0f6082abdd859faf0c8 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 157 | 140 | 5 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | (03)_Secretory-(3)_72hpi|(03)_Secretory / shred by cell type and Timepoint | 1.43e-04 | 158 | 140 | 5 | 20563d03183b63aafc9c389f3f03781140702249 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 162 | 140 | 5 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 164 | 140 | 5 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 164 | 140 | 5 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 164 | 140 | 5 | a187bd5beca017ef657ef07c006e7f94ea3b911b | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-04 | 165 | 140 | 5 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 165 | 140 | 5 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 165 | 140 | 5 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 165 | 140 | 5 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 165 | 140 | 5 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.80e-04 | 166 | 140 | 5 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 167 | 140 | 5 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 168 | 140 | 5 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HG-U133A | HNRNPDL TBRG4 VWA8 RANBP6 SRBD1 BHLHE40 JARID2 COMMD8 STK38L | 3.58e-06 | 196 | 140 | 9 | 1921_DN |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A | 3.74e-06 | 197 | 140 | 9 | 1931_DN | |
| Disease | Malignant neoplasm of breast | ACAP1 ERBB3 ABCA3 COL19A1 OBSCN XDH TTC3 AKAP12 CHRND KMT2D AKAP9 FKTN MTOR SYNE2 MMP14 EIF3M VDR | 1.06e-05 | 1074 | 137 | 17 | C0006142 |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.35e-04 | 56 | 137 | 4 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Limb-girdle muscular dystrophy | 2.35e-04 | 26 | 137 | 3 | cv:C0686353 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.64e-04 | 27 | 137 | 3 | DOID:3021 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 2.66e-04 | 268 | 137 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Malignant Neoplasms | 3.36e-04 | 128 | 137 | 5 | C0006826 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.36e-04 | 128 | 137 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.36e-04 | 128 | 137 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.36e-04 | 128 | 137 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.36e-04 | 128 | 137 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.36e-04 | 128 | 137 | 5 | C0007134 | |
| Disease | Muscular Dystrophies, Limb-Girdle | 4.40e-04 | 32 | 137 | 3 | C0686353 | |
| Disease | prostate cancer (implicated_via_orthology) | 4.82e-04 | 33 | 137 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.52e-04 | 148 | 137 | 5 | C0279702 | |
| Disease | Nephronophthisis | 7.54e-04 | 9 | 137 | 2 | cv:C0687120 | |
| Disease | cathepsin F measurement | 7.54e-04 | 9 | 137 | 2 | EFO_0022038 | |
| Disease | serum alanine aminotransferase measurement | ERBB3 L2HGDH XDH JARID2 MAP4K5 AHNAK AHCY TJP2 PATJ SLC33A1 SENP7 TJP3 | 7.60e-04 | 869 | 137 | 12 | EFO_0004735 |
| Disease | dilated cardiomyopathy (is_marker_for) | 7.92e-04 | 39 | 137 | 3 | DOID:12930 (is_marker_for) | |
| Disease | nevus count, cutaneous melanoma | 8.69e-04 | 91 | 137 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | level of Ceramide (d40:1) in blood serum | 1.15e-03 | 11 | 137 | 2 | OBA_2045185 | |
| Disease | Cardiomyopathy | 1.37e-03 | 47 | 137 | 3 | cv:C0878544 | |
| Disease | cataract (biomarker_via_orthology) | 1.61e-03 | 13 | 137 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 1.76e-03 | 110 | 137 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | breast cancer (is_marker_for) | 1.76e-03 | 185 | 137 | 5 | DOID:1612 (is_marker_for) | |
| Disease | episodic memory | 1.83e-03 | 52 | 137 | 3 | EFO_0004333 | |
| Disease | chronic kidney disease (is_implicated_in) | 1.88e-03 | 14 | 137 | 2 | DOID:784 (is_implicated_in) | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 1.88e-03 | 14 | 137 | 2 | cv:C2931907 | |
| Disease | Metastatic melanoma | 2.04e-03 | 54 | 137 | 3 | C0278883 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.16e-03 | 15 | 137 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.16e-03 | 15 | 137 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.16e-03 | 15 | 137 | 2 | C0154091 | |
| Disease | Autosomal recessive primary microcephaly | 2.16e-03 | 15 | 137 | 2 | cv:C3711387 | |
| Disease | diacylglycerol 44:7 measurement | 2.46e-03 | 16 | 137 | 2 | EFO_0020069 | |
| Disease | Inborn Errors of Metabolism | 2.78e-03 | 17 | 137 | 2 | C0025521 | |
| Disease | cutaneous melanoma, hair color | 3.03e-03 | 62 | 137 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Carcinoma of bladder | 3.12e-03 | 18 | 137 | 2 | C0699885 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 3.17e-03 | 63 | 137 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Cardiomyopathies | 3.22e-03 | 130 | 137 | 4 | C0878544 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 3.47e-03 | 19 | 137 | 2 | DOID:2876 (is_marker_for) | |
| Disease | platelet measurement | 3.61e-03 | 315 | 137 | 6 | EFO_0005036 | |
| Disease | breast carcinoma (is_marker_for) | 3.62e-03 | 66 | 137 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Benign Neoplasm | 3.94e-03 | 68 | 137 | 3 | C0086692 | |
| Disease | Neoplasms | 3.94e-03 | 68 | 137 | 3 | C0027651 | |
| Disease | Bladder Neoplasm | 4.19e-03 | 140 | 137 | 4 | C0005695 | |
| Disease | hypertension (biomarker_via_orthology) | 4.24e-03 | 227 | 137 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 4.24e-03 | 21 | 137 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Malignant neoplasm of urinary bladder | 4.30e-03 | 141 | 137 | 4 | C0005684 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.44e-03 | 71 | 137 | 3 | DOID:0050700 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKAGHSLELIEPLIK | 301 | P11473 | |
| TGLKLVEEGVPKEHL | 331 | O00400 | |
| VEEGVPKEHLALLAV | 336 | O00400 | |
| KAKTELVGPAHLIHE | 511 | O14727 | |
| EPHGLTNKKLEEVEL | 991 | P21860 | |
| GVKKLFLETLPELLH | 346 | Q07001 | |
| PLSKELGEHGKEILL | 1516 | Q99996 | |
| DHLSKDKPELEVVLT | 2456 | Q99996 | |
| ELVHPALERSLKKLG | 96 | Q5T2L2 | |
| ILPGKELEEKIHSLQ | 921 | O94986 | |
| HLPGALAEKRLSKVE | 181 | Q7RTU5 | |
| LPEHLKLTTLGHLEK | 71 | Q9C0J9 | |
| PSLPEEEKLKLAHAK | 1256 | O14514 | |
| PAGAHLVLEEKSSEK | 1446 | Q02952 | |
| KDLLPEHLKLTTLGH | 76 | O14503 | |
| QKDLKIPGLEHASIE | 241 | Q96G28 | |
| ALDKGHEVTLEALPK | 306 | Q96QA5 | |
| AEPEDLVAGIKIKHL | 521 | Q99758 | |
| LDLHLKSPKAKGEVD | 2391 | Q09666 | |
| LPAIHVEGLDIKAKA | 5126 | Q09666 | |
| RHVLLKQKELGGEEP | 241 | Q15027 | |
| DSELIKLHLILKAPG | 3296 | Q96M86 | |
| LGEPHKILSLQKHLE | 671 | Q9NVE4 | |
| DLLPIKDGKLVFVHS | 166 | P07384 | |
| DLSLTHKILPDDPDK | 1281 | O14646 | |
| TLHVPSKLDAEKLVG | 36 | Q02487 | |
| DLNKGIEAKIHTLLP | 96 | Q14627 | |
| KHIKELGRGLPTDKI | 401 | P50281 | |
| TLKEKIHKGIPLEEL | 666 | Q6ZP01 | |
| EKIHKDHLIGIGIAP | 876 | P48200 | |
| LELKEHKLDGKLIDP | 206 | O14979 | |
| LLHQELGKGPTKEEL | 451 | Q96TA1 | |
| LPDGHRVKKEVDAAL | 716 | Q9ULE6 | |
| LKTLHPDLGTDKDKE | 211 | P00338 | |
| PLDETLKKALTGHLE | 91 | P04083 | |
| KDTLGKPAAKDVHLV | 246 | Q8NBL1 | |
| DPGLREKLSLNLDHK | 201 | O60568 | |
| LTHDKGLPKHLEELD | 2061 | Q9Y618 | |
| GLPKHLEELDKSHLE | 2066 | Q9Y618 | |
| GELKELLEKELHPVL | 31 | Q5D862 | |
| KIKSPEDHIGAVLER | 386 | Q13823 | |
| LEKLQESGEVPVHKL | 36 | O14910 | |
| HSLDPGDIRDELKKL | 671 | Q6PRD1 | |
| HPSLSIGVLEKEKDL | 71 | Q9H9P8 | |
| KIDRLDGAHAPELTK | 96 | O76003 | |
| KPIKELEVKQTHLEG | 476 | Q13201 | |
| ILLHGKEQPLDEELK | 521 | P05023 | |
| DHLLTLKPVKFLEGE | 221 | Q7L2H7 | |
| LKPVKFLEGELIHDL | 226 | Q7L2H7 | |
| KEPLEKGGIVLIDAH | 3611 | Q15751 | |
| LPHSKEDLKLDLGEK | 26 | Q8N371 | |
| KKARADHGLIPDVKL | 166 | Q8N371 | |
| PLHIVLESLKREGKE | 251 | Q9Y6W6 | |
| ESDPLHKELLEKLVL | 406 | Q6L8Q7 | |
| IIIKHKKLGPRGDVD | 451 | P16885 | |
| LVHRISGDKKLEEIP | 286 | O00232 | |
| SVLLPLVAKEGKLHL | 41 | P0C024 | |
| LSLHLDVKENGEVKP | 141 | Q9NX08 | |
| RLAIDGLHLPKELKD | 266 | Q9BR09 | |
| VSELLEKHGLEKPIS | 1046 | A2RRP1 | |
| ALSGKIELHGKPIEV | 56 | O00425 | |
| ILDIDHGKPVKNALD | 236 | Q13093 | |
| HPLIKAKGVEILDEG | 2331 | Q96RW7 | |
| AVAEAKGHPALEKLR | 726 | Q9UG01 | |
| RKEEPLAAKEALGHL | 5511 | Q5VST9 | |
| KEVTLHKDGPLGETV | 166 | Q92900 | |
| LHKDKKEGRPTVILG | 266 | Q8N878 | |
| EIDLKLLTKVLAPEH | 151 | Q96FT9 | |
| KHPGDAEKITQLKEL | 1571 | Q8IZD9 | |
| GDAGHLQLLKVKIEP | 2441 | Q9H799 | |
| EKVLIHLSPTGKIVD | 2341 | Q8TD57 | |
| KVPRLKEEHGIELSS | 1351 | O14647 | |
| SDGKPVDIELHQLKI | 216 | Q14993 | |
| VHSGLKLVKPDDIGR | 56 | Q9UKT4 | |
| ILVPHGDKESSDKKI | 911 | Q8TF40 | |
| PLGATKIDHLDLKTV | 1381 | O75417 | |
| KDKETGDIKELHAPL | 266 | Q14534 | |
| PLKHKFGKVEDSLEL | 341 | O75072 | |
| VKAGTLEKLVEHLVP | 116 | Q12967 | |
| HLVKEIAEDPVDILG | 436 | Q9H9L4 | |
| HGDPAKVVELKNLEL | 51 | Q9BV79 | |
| KDILLLKTVKAHDGP | 891 | Q6ZMW3 | |
| EPLIISDIKKGSVAH | 581 | Q9C0E4 | |
| HLIKVKLEGHELPAD | 506 | Q9H4M9 | |
| LPKKLDEAVAEAHLG | 386 | P23526 | |
| HLSLKLLPGNDVEIK | 136 | Q6UVJ0 | |
| LKIDIIKHPNETDGK | 91 | Q8N5C7 | |
| RLSHLLSEKPEDKGL | 106 | Q969Z0 | |
| HTGELAAVKIIKLEP | 41 | Q9Y4K4 | |
| ELRKDLGFSKLDHPV | 871 | Q9H4L5 | |
| LVVTLHEKKGDVALP | 156 | P09619 | |
| GEEHELSPKEISEKL | 406 | Q16363 | |
| KLLIKHDSNIGIPDV | 166 | Q9Y283 | |
| EKEILEKRKGPLEGH | 726 | Q92833 | |
| LLGVDLSKIEKHPEA | 161 | Q96E29 | |
| EKELIHLLPIKDKSG | 146 | Q8WTT2 | |
| LGADTKQKLELKEHP | 151 | Q9P2E2 | |
| EILDGVELGEPAHKK | 2456 | P42345 | |
| IHKDSADLLPLDGLK | 36 | Q9NQ35 | |
| LHVKIKGEEFPLTLG | 106 | Q8WWV3 | |
| QPILAKEGKDHLDLL | 111 | O95197 | |
| EEGPVEHKSSEILKL | 446 | Q9BQF6 | |
| RDIKPDNLLLDSKGH | 211 | Q15208 | |
| PGLLSVEEKKKIGHL | 416 | Q9NUP7 | |
| HRDIKPDNLLLDAKG | 211 | Q9Y2H1 | |
| RTVIDGLDLLKKEHP | 886 | Q9UPR3 | |
| TPAAHLEIKPDELAK | 201 | Q9NUQ6 | |
| RESPGELISKHKEAL | 871 | Q8WXH0 | |
| VKLGELFHDLPKAVL | 431 | Q9BXS9 | |
| LLHKGKPVSFELDKV | 481 | Q9BVG8 | |
| KTLHLEPLKALLEGL | 71 | O60811 | |
| EHLEELGGILKAKLE | 796 | O60518 | |
| LAELVKIEPKHIGVG | 666 | Q8N5C6 | |
| HKKDLLEVPEIKTEG | 226 | O60284 | |
| VKDLEPELLRHLAKG | 611 | Q9H2X0 | |
| LLLVDPEGKVRTKDH | 571 | Q6S5L8 | |
| LKALKEPAGLHEVQD | 146 | Q6J9G0 | |
| LTEIHLSPGKFEVLK | 446 | O95498 | |
| VDLSHIPLKDPLLFK | 936 | A0JNW5 | |
| PLHSDLQILKEKEGI | 251 | Q8WVN8 | |
| KKLEAGLENHITILP | 721 | Q9P2K2 | |
| DKHALLDVTPKAVDL | 786 | Q9UDY2 | |
| DHNLEDLKTELGKKP | 491 | A4D1E1 | |
| LPGLEKLLHHVTEEK | 131 | Q5TBB1 | |
| LGAKLHPTLKLEELT | 316 | Q8NER1 | |
| ADLPGELHIIELEKD | 1231 | Q8NI35 | |
| KKSEVKDLGPLEIHL | 291 | Q6ZV73 | |
| HLDDETLAKLIAKIP | 411 | Q92753 | |
| HVLSELKEVEPKLAA | 891 | P53804 | |
| KTIHLPEQLKEDGTL | 36 | Q9NXF1 | |
| LDLKAQHPDAKLVVG | 246 | P47989 | |
| PKGRHKIIILDEADS | 131 | P35250 | |
| GDIEEAKKRLELPEH | 121 | Q969G6 | |
| VKEGVVGPELHHKLL | 2891 | Q15149 | |
| VIAEKDKHALLDVTP | 666 | O95049 | |
| PLNIDHLGEDKLRDK | 196 | P45378 | |
| KELLHKELPSFVGEK | 36 | P29034 | |
| ASLLKNGEPEAELHK | 1691 | Q5VWN6 | |
| PDTHLLKLLKTLEGH | 386 | Q9H7D7 | |
| LKPALSDHSEGEKVD | 371 | Q5VZ18 | |
| DSPLVKAVKLGHILV | 831 | A3KMH1 | |
| ELPSSVIHKDDLELK | 571 | Q6P2D8 | |
| EILGFDILLDHKLKP | 371 | A6NNM8 | |
| PLLIEDLLEHEKKEL | 3246 | O14686 | |
| KPENILLDEEGHIKI | 186 | Q15349 | |
| AGHKTLVPELIKELN | 676 | P22033 | |
| LGPQSVLLEKHEDKS | 176 | Q9HD90 |